You are using an out of date browser that our site does not support. Please, update your browser for a faster browsing experience, better security, and to experience the web's latest features. Click here to update or install a different browser.
Methodist Healthcare Blood and Marrow Transplant Center, a department of West Cancer Center, has received internationally-recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center. By demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration, Methodist Healthcare Blood and Marrow Transplant Center has earned FACT Accreditation for Adult Autologous Hematopoietic Progenitor Cell Transplantation; Peripheral Blood Cellular Therapy Product Collection; and Cellular Therapy Product Processing with Minimal Manipulation.
“I am so proud that our team has been able to bring this accreditation to West Cancer Center,” according to Erich Mounce, CEO. “The enormous amount of work and commitment in order to obtain accreditation reflects our ongoing dedication to excellence and the highest quality care.”
FACT is an internationally-recognized accrediting body for hospitals and medical institutions offering stem cell transplant, and indicates the accredited institution has met the most rigorous standards in every aspect of stem cell therapy. This covers the entire spectrum of stem cell therapy, from clinical care to donor management, cell collection, processing, storage, administration, and cell release. FACT-JACIE Standards are defined by leading experts based on the latest knowledge of the field of cellular therapy transplantation. Methodist Healthcare Blood and Marrow Transplant Center has been found to be in compliance with these rigorous standards as well as governmental regulations.
“We are pleased that Methodist Healthcare Blood and Marrow Transplant Center has met the requirements of the Foundation and has been granted accreditation for Adult Autologous Hematopoietic Progenitor Cell Transplantation; Peripheral Blood Cellular Therapy Product Collection; and Cellular Therapy Product Processing with Minimal Manipulation,” said Dr. Phyllis Warkentin, FACT’s Chief Medical Officer. Accreditation is attained through evaluation of submitted documentation and on-site inspection to determine if an organization is in compliance with current FACT standards and the United States Food and Drug Administration’s current rules for Good Tissue Practice. FACT Standards are defined by leading experts based on the latest knowledge of the field of cellular therapy.
In January, 2012, The West Clinic, Methodist Healthcare, and the University of Tennessee Health Science Center joined forces to establish the West Cancer Center, a comprehensive, cancer center for the benefit of patients throughout the Mid-South. West Cancer Center is committed to be a world-class leader in oncology research and cancer care; enhance the lives of cancer patients through comprehensive, compassionate care, community outreach and collaborative efforts with community and academic physicians; and to promote understanding and treatment of cancer through innovative training programs, translational research and clinical discovery. Development of a translational medicine department with expansion of the Phase I clinical trial program and bone marrow/stem cell transplant program are in progress. West Cancer Center is involved in rapid learning initiatives in oncology and will leverage the assets of UT Health Science Center to promote population health and reduction of disparities for cancer care in our region. An active medical oncology fellowship program has expanded and plans are underway to initiate surgical and breast oncology fellowships.